GE HealthCare (GEHC) has revealed its plans for this week's European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna.
GEHC said in a statement that it intends to add Spectronic Medical AB’s FDA 510(k)-cleared and CE-marked MRI Planner software to its portfolio for MR-only radiotherapy workflows.
GEHC MR Contour DL images. Courtesy GE HealthCare.
The firm’s new MR Contour DL is an AI model designed for organs at risk (OAR) segmentation that uses the soft-tissue detail of MR images to create precise organ contours of OAR during radiation therapy treatment planning.
The FDA 510(k)-cleared model will be integrated into GEHC’s iRT digital platform for radiation therapy workflow management.
In addition, GEHC said that it plans to highlight the capabilities of the latest version of its iRT software at ESTRO 2025. The updated version includes a new orchestrator that enables the hosting and integration of third-party AI applications, allowing them to run simultaneously, and the embedding of MRI workflows into the software.
